DE69934135D1 - Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen - Google Patents

Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Info

Publication number
DE69934135D1
DE69934135D1 DE69934135T DE69934135T DE69934135D1 DE 69934135 D1 DE69934135 D1 DE 69934135D1 DE 69934135 T DE69934135 T DE 69934135T DE 69934135 T DE69934135 T DE 69934135T DE 69934135 D1 DE69934135 D1 DE 69934135D1
Authority
DE
Germany
Prior art keywords
dosage forms
active substances
forms containing
masked active
tasty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934135T
Other languages
English (en)
Other versions
DE69934135T2 (de
Inventor
Djelila Mezaache
G Raiden
P Sanghvi
J Szedlock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valeant International Bermuda
Original Assignee
Biovail Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Technologies Ltd filed Critical Biovail Technologies Ltd
Application granted granted Critical
Publication of DE69934135D1 publication Critical patent/DE69934135D1/de
Publication of DE69934135T2 publication Critical patent/DE69934135T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69934135T 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen Expired - Lifetime DE69934135T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/183,501 US6165512A (en) 1998-10-30 1998-10-30 Dosage forms containing taste masked active agents
US183501 1998-10-30
PCT/US1999/025059 WO2000025755A1 (en) 1998-10-30 1999-10-26 Dosage forms containing taste masked active agents

Publications (2)

Publication Number Publication Date
DE69934135D1 true DE69934135D1 (de) 2007-01-04
DE69934135T2 DE69934135T2 (de) 2007-07-26

Family

ID=22673073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934135T Expired - Lifetime DE69934135T2 (de) 1998-10-30 1999-10-26 Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen

Country Status (8)

Country Link
US (1) US6165512A (de)
EP (1) EP1124540B1 (de)
AT (1) ATE345782T1 (de)
AU (1) AU1232600A (de)
CA (1) CA2348451C (de)
DE (1) DE69934135T2 (de)
ES (1) ES2278466T3 (de)
WO (1) WO2000025755A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
BR9917315A (pt) * 1999-05-21 2002-07-30 Kissei Pharmaceutical Composições medicinais para liberação imediata para uso oral
DE19940740A1 (de) * 1999-08-31 2001-03-01 Gruenenthal Gmbh Pharmazeutische Salze
CN1273608C (zh) * 2001-02-09 2006-09-06 荷兰联合利华有限公司 通过发酵制备一种或多种抑制素的方法
EP1367999A4 (de) * 2001-02-16 2007-04-18 Lavipharm Lab Inc Wasserlösliche komplexe mit angenehmem geschmack
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
BR0212951A (pt) 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas
EP1941878A1 (de) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
JP2005526042A (ja) * 2002-02-06 2005-09-02 キング・ファーマシューティカルズ・インコーポレイティッド 経口小児用トリメトベンズアミド製剤および方法
US20070087981A1 (en) * 2002-02-08 2007-04-19 Lavipharm Laboratories, Inc. Water Soluble and Palatable Complexes
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US6689343B1 (en) * 2002-11-05 2004-02-10 Ultradent Products, Inc. Hemostatic and acid etch compositions containing sucralose
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053651A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
PL1691787T3 (pl) 2003-12-04 2008-11-28 Pfizer Prod Inc Sposób wytwarzania farmaceutycznych systemów wielocząstkowych
BRPI0417348A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
EP1621187A1 (de) * 2004-07-26 2006-02-01 AstraZeneca AB Pharmazeutische multipartikuläre Tablettenzubereitungen und Prozess zu ihrer Herstellung
US20060039966A1 (en) * 2004-08-12 2006-02-23 Miller Bruce A Jr Dosage delivery apparatus for improving user acceptance of oral supplements and medicaments and methods for manufacturing same
EP1640401A3 (de) * 2004-09-24 2006-04-12 Clariant Produkte (Deutschland) GmbH Polyethylenglykol und Alkoholethoxylate und deren Herstellung
US7611695B2 (en) * 2004-11-15 2009-11-03 Ultradent Products, Inc. Flavored hemostatic and acid etching compositions
PT2486942T (pt) 2004-11-24 2019-01-18 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
WO2008109018A1 (en) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
EP2389155A2 (de) * 2009-01-16 2011-11-30 ADD Technologies Ltd. Im mund zerfallende tabletten zur behandlung von schmerzen
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
BR112012024356A2 (pt) 2010-03-26 2016-05-24 Philip Morris Products Sa inibição de irritação sensorial durante o consumo de tabaco não fumável
MX364560B (es) * 2010-09-20 2019-05-02 Spi Pharma Inc Star Proceso de microencapsulacion y producto.
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
US9662345B2 (en) 2013-06-14 2017-05-30 Professional Compounding Centers Of America Antibiotic composition for inhalation and irrigation
EP3061501A1 (de) 2015-02-27 2016-08-31 Rottapharm Ltd. Zusammensetzung zur behandlung von akne
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2016196804A1 (en) * 2015-06-04 2016-12-08 Balchem Corporation Hydration control for choline salts
MX2018000020A (es) * 2015-07-09 2019-06-06 Uniwell Laboratories Llc Composiciones farmaceuticas.
EP3117825A1 (de) 2015-07-16 2017-01-18 Rottapharm S.p.A. Orale formulierung mit berberin und morus-alba-extrakt
BR112018006546B1 (pt) * 2015-10-02 2022-12-13 Dsm Ip Assets B.V. Uso de uma partícula revestida
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP7060711B2 (ja) 2018-01-16 2022-04-26 アプライド マテリアルズ インコーポレイテッド 金属酸化物でカプセル化された薬物組成物及びその調製方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387431A (en) * 1991-10-25 1995-02-07 Fuisz Technologies Ltd. Saccharide-based matrix
DE68924808D1 (de) * 1988-07-26 1995-12-21 Univ Rutgers Vorrichtungen und Verfahren zur Wachstumsförderung bei Bratgeflügel.
EP0559897B1 (de) * 1990-11-30 1998-03-04 Yamanouchi Pharmaceutical Co. Ltd. Überdeckte zusammensetzung mit schneller freisetzung
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5518551A (en) * 1993-09-10 1996-05-21 Fuisz Technologies Ltd. Spheroidal crystal sugar and method of making
CA2192587A1 (en) * 1994-06-14 1995-12-21 Fuisz Technologies, Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5834033A (en) * 1997-05-12 1998-11-10 Fuisz Technologies Ltd. Apparatus for melt spinning feedstock material having a flow restricting ring
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions

Also Published As

Publication number Publication date
CA2348451C (en) 2009-01-27
EP1124540B1 (de) 2006-11-22
US6165512A (en) 2000-12-26
ES2278466T3 (es) 2007-08-01
EP1124540A1 (de) 2001-08-22
AU1232600A (en) 2000-05-22
ATE345782T1 (de) 2006-12-15
WO2000025755A1 (en) 2000-05-11
DE69934135T2 (de) 2007-07-26
CA2348451A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
DE69934135D1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
AR026745A1 (es) Composiciones de eplerenona nanoparticulada
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
BG104693A (en) Fast melting oral dosage form
ES2181055T3 (es) Formulaciones galenicas que contienen antagonistas de opiaceos.
MY125651A (en) Eplerenone compositions
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
ATE365540T1 (de) Behandlung akuter gesundheitsstörungen durch die sublingual verabreichung einer pharmazeutischen zusammensetzung
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
TR200200065T2 (tr) Dış salgılama bozukluklarının tedavisi için terkip
SE0102843L (sv) Stabiliserad oral farmaceutisk komposition innehållande jodid och jodat och metod
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
HUP0103216A2 (hu) Gasztrointesztinális hatóanyagokat tartalmazó mukoadhezív készítmények
SE9201628D0 (sv) Pharmaceutical composition
EP1123696A4 (de) Zubereitungen für die mundhöhle
MY127350A (en) Flash-melt oral dose formulations
IL141236A0 (en) New oral formulations for 5-ht4 agonists or antagonists
BG103005A (en) Active substance-containing sedimented silicic acids
ATE402691T1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
HUP0402178A2 (hu) 5 HT1 antagonista hatóanyagot tartalmazó gyógyszerkészítmény
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
HUP0303178A2 (hu) Eljárások és készítmények gyógyászatilag aktív anyagok ízének csökkentésére
WO2000066070A3 (de) Verwendung nanoskaliger antimikrobieller wirkstoffe in der mund- und/oder zahnpflege
TR200100863T2 (tr) (2S,3S,5R)-2-(3,5-Diflorofenil)-3,5-dimetil-2-morfolinol ve etkili dengeleyici miktarda alginik asit içeren oral dozaj formülasyonları.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOVAIL LABORATORIES INTERNATIONAL S.R.L., COL, BB

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE VON KREISLER, SELTING, WERNER ET COL

8364 No opposition during term of opposition